RxDoctor Payments Data

Edward Apicella

Interventional Pain Medicine · Albany, NYNPI 1528051869

Payments from drug & device makers

What this record shows

Abbott accounts for 63.9% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2019 at $8,086 and has fallen 98.1% since, to $151 in 2023.

$12,720in general payments, 2019–2025

Across 185 payments — averaging $68.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$8K
  • Nevro Corp.$2K
  • Boston Scientific$1K
  • Medtronic$265
  • Scilex Pharmaceuticals Inc.$186
  • Biohaven Pharmaceuticals, Inc.$158
  • plus $558 from 14 others

What the payments were for

  • Consulting fees$6,10448%
  • Food & beverage$6,61652%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,720 in reported general payments places this provider in the 75th percentile of 132 interventional pain medicine providers in New York.

See all interventional pain medicine providers in New York

Other interventional pain medicine in Albany

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →